UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 88 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,000 | -50.0% | 6,830 | -35.5% | 0.00% | – |
Q2 2022 | $6,000 | -45.5% | 10,581 | +5.8% | 0.00% | – |
Q1 2022 | $11,000 | +83.3% | 10,000 | +153.2% | 0.00% | – |
Q4 2021 | $6,000 | -72.7% | 3,950 | -43.0% | 0.00% | – |
Q3 2021 | $22,000 | +266.7% | 6,933 | +454.6% | 0.00% | – |
Q2 2021 | $6,000 | -76.0% | 1,250 | -69.7% | 0.00% | – |
Q1 2021 | $25,000 | +108.3% | 4,129 | +85.6% | 0.00% | – |
Q4 2020 | $12,000 | -36.8% | 2,225 | -59.3% | 0.00% | – |
Q3 2020 | $19,000 | -55.8% | 5,468 | +10.5% | 0.00% | – |
Q2 2020 | $43,000 | -42.7% | 4,948 | -61.8% | 0.00% | – |
Q1 2020 | $75,000 | -67.5% | 12,959 | -59.6% | 0.00% | – |
Q4 2019 | $231,000 | +69.9% | 32,061 | +43.4% | 0.00% | – |
Q3 2019 | $136,000 | -58.7% | 22,365 | -35.5% | 0.00% | – |
Q2 2019 | $329,000 | +11.5% | 34,698 | -4.7% | 0.00% | – |
Q1 2019 | $295,000 | -47.2% | 36,400 | +5.8% | 0.00% | – |
Q4 2018 | $559,000 | -4.4% | 34,390 | -4.2% | 0.00% | – |
Q3 2018 | $585,000 | +379.5% | 35,898 | +342.6% | 0.00% | – |
Q2 2018 | $122,000 | – | 8,111 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 1,571,981 | $8,237,000 | 9.91% |
Invus Financial Advisors, LLC | 1,094,998 | $5,738,000 | 2.40% |
Founders Fund V Management, LLC | 491,751 | $2,577,000 | 0.66% |
ALGERT GLOBAL LLC | 51,890 | $272,000 | 0.08% |
Arbor Wealth Management, LLC | 25,888 | $136,000 | 0.05% |
Moloney Securities Asset Management, LLC | 41,950 | $220,000 | 0.05% |
PDT Partners, LLC | 78,800 | $413,000 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 394,957 | $2,070,000 | 0.02% |
Fort Point Capital Partners LLC | 10,000 | $52,000 | 0.01% |
Baillie Gifford | 3,803,014 | $19,928,000 | 0.01% |